CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Inc. COP Y/Y Annual
Teleflex Incorporated  (TFX)
Other Ticker:  
 
 

TFX's Income from Cont. Operations Growth by Quarter and Year

Teleflex Incorporated's Income from Cont. Operations results by quarter and year




TFX Income from Cont. Operations (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 31.18 78.11 127.46
III Quarter September - 137.67 101.88 199.51
II Quarter June 80.17 111.42 105.56 83.28
I Quarter March 15.74 77.30 77.37 74.87
FY   95.91 357.57 362.92 485.12



TFX Income from Cont. Operations second quarter 2024 Y/Y Growth Comment
Teleflex Incorporated reported fall in Income from Cont. Operations in the second quarter 2024 by -28.05% to $ 80.17 millions, from the same quarter in 2023.
The drop in the second quarter 2024 Teleflex Incorporated's Income from Cont. Operations compares unfavorably to the Company's average Income from Cont. Operations rise of 30.66%.

Looking into second quarter 2024 results within Medical Equipment & Supplies industry 32 other companies have achieved higher Income from Cont. Operations growth. While Teleflex Incorporated' s Income from Cont. Operations drop of -28.05% ranks overall at the positon no. 1322 in the second quarter 2024.


TFX Income from Cont. Operations ( Y/Y Growth %) 2024
 2023 2022 2021
IV Quarter December - -60.08 % -38.72 % 66.4 %
III Quarter September - 35.13 % -48.93 % 71.09 %
II Quarter June -28.05 % 5.55 % 26.75 % 627.97 %
I Quarter March -79.64 % -0.09 % 3.34 % -42.91 %
FY   - -1.47 % -25.19 % 44.47 %

Financial Statements
Teleflex Incorporated's second quarter 2024 Income from Cont. Operations $ 80.17 millions TFX's Income Statement
Teleflex Incorporated's second quarter 2023 Income from Cont. Operations $ 111.42 millions Quarterly TFX's Income Statement
New: More TFX's historic Income from Cont. Operations Growth >>


TFX Income from Cont. Operations (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
IV Quarter December - -77.35 % -23.33 % -36.11 %
III Quarter September - 23.56 % -3.49 % 139.57 %
II Quarter June 409.31 % 44.14 % 36.44 % 11.23 %
I Quarter March -49.52 % -1.04 % -39.3 % -2.26 %
FY (Year on Year)   - -1.47 % -25.19 % 44.47 %


Current TFX Income Statement >> Back to TFX Growth rate Comparisons >>


Income from Cont. Operations second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #33
Healthcare Sector #78
Overall #1322

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
627.81 % 30.66 % -86.27 %
(Jun 27 2021)   (Jun 28 2020)
Income from Cont. Operations second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #33
Healthcare Sector #78
Overall #1322
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
627.81 % 30.66 % -86.27 %
(Jun 27 2021)   (Jun 28 2020)

Income from Cont. Operations by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Teleflex Incorporated's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
919.01 % 37.15 % -91.28 %
(Sep 27 2020)  


TFX's II. Quarter Q/Q Income from Cont. Operations Comment
Teleflex Incorporated achieved in the II. Quarter 2024 above company average sequential Income from Cont. Operations doubling of 409.31%, to $ 80.17 millions, from $15.74 millions in the first quarter.
Teleflex Incorporated is impressively improving, with reporting above average growth, and also improving pace, Christian De Luca, a business researcher located in Rome added.

Within Medical Equipment & Supplies industry only one company achieved higher sequential Income from Cont. Operations growth. While Teleflex Incorporated's Income from Cont. Operations growth quarter on quarter, overall rank is 69.


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #2
Healthcare Sector #8
Overall #69
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #2
Healthcare Sector #8
Overall #69
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
919.01 % 37.15 % -91.28 %
(Sep 27 2020)  


TFX's II. Quarter Q/Q Income from Cont. Operations Comment
Teleflex Incorporated achieved in the II. Quarter 2024 above company average sequential Income from Cont. Operations doubling of 409.31%, to $ 80.17 millions, from $15.74 millions in the first quarter.
Teleflex Incorporated is going from strength to strength, not only recording better then normal gain, and also improving speed.

Within Medical Equipment & Supplies industry only one company achieved higher sequential Income from Cont. Operations growth. While Teleflex Incorporated's Income from Cont. Operations growth quarter on quarter, overall rank is 69.


Teleflex Incorporated's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Oct 01 2023)		 12 Months Ending
(Jul 02 2023)
Cumulative Income from Cont. Operations 12 Months Ending $ 264.76 $ 296.02 $ 357.57 $ 404.50 $ 368.71
Y / Y Income from Cont. Operations Growth (TTM) -28.19 % -18.42 % -1.47 % -1.88 % -27.69 %
Year on Year Income from Cont. Operations Growth Overall Ranking # 1192 # 1160 # 980 # 1051 # 1591
Seqeuential Income from Cont. Operations Change (TTM) -10.56 % -17.21 % -11.6 % 9.71 % 1.62 %
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 1192 # 1160 # 980 # 1051 # 1591

New: More TFX's historic Income from Cont. Operations Growth >>



Cumulative Income from Cont. Operations growth Comment
Teleflex Incorporated's cumulative 12 months Income from Cont. Operations continue to drop, but on the faster rate at -28.19% year on year, at Jun 30 2024 compare to the -18.42% decrease at Mar 31 2024. If the Teleflex Incorporated's fiscal year would end at Jun 30 2024, annual Income from Cont. Operations would be $265 millions.

In the Healthcare sector 79 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 1160 to 1192.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
568.52 %
28.41 %
-74.49 %
(Sep 29 2019)  

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 32
Healthcare Sector # 80
Overall # 1184

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
568.52 %
28.41 %
-74.49 %
(Sep 29 2019)  


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 24
Sector # 62
S&P 500 # 789
Cumulative Income from Cont. Operations growth Comment
Teleflex Incorporated's cumulative 12 months Income from Cont. Operations continue to drop, but on the faster rate at -28.19% year on year, at Jun 30 2024 compare to the -18.42% decrease at Mar 31 2024. If the Teleflex Incorporated's fiscal year would end at Jun 30 2024, annual Income from Cont. Operations would be $265 millions.

In the Healthcare sector 79 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 1160 to 1192.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
568.52 %
28.41 %
-74.49 %
(Sep 29 2019)  


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 32
Healthcare Sector # 80
Overall # 1184

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
568.52 %
28.41 %
-74.49 %
(Sep 29 2019)  


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 24
Sector # 62
S&P 500 # 789




Other Income from Cont. Operations Growth
Medical Equipment & Supplies Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
TFX's Income from Cont. Operations Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for TFX's Competitors
Income from Cont. Operations Growth for Teleflex Incorporated's Suppliers
Income from Cont. Operations Growth for TFX's Customers

You may also want to know
TFX's Annual Growth Rates TFX's Profitability Ratios TFX's Asset Turnover Ratio TFX's Dividend Growth
TFX's Roe TFX's Valuation Ratios TFX's Financial Strength Ratios TFX's Dividend Payout Ratio
TFX's Roa TFX's Inventory Turnover Ratio TFX's Growth Rates TFX's Dividend Comparisons



Companies with similar Income from Cont. Operations drop for the quarter ending Jun 30 2024 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Jun 30 2024
Biogen Inc -1.63%$ -1.635 millions
Embecta Corp -3.29%$ -3.289 millions
Quest Diagnostics Inc-3.61%$ -3.614 millions
Abbott Laboratories-5.31%$ -5.309 millions
Zoetis Inc -6.87%$ -6.866 millions
Idexx Laboratories Inc-9.34%$ -9.337 millions
Prestige Consumer Healthcare Inc -11.89%$ -11.893 millions
Align Technology inc -13.64%$ -13.639 millions
National Research Corporation-15.10%$ -15.097 millions
Dariohealth Corp -17.94%$ -17.938 millions
Bristol myers Squibb Company-18.92%$ -18.922 millions
Organon and Co -19.42%$ -19.421 millions
U S Physical Therapy Inc-21.21%$ -21.206 millions
Pacira Biosciences inc -26.69%$ -26.693 millions
Privia Health Group Inc -27.00%$ -26.997 millions
West Pharmaceutical Services Inc -28.24%$ -28.240 millions
Neurocrine Biosciences Inc -31.94%$ -31.937 millions
Abbvie Inc -32.26%$ -32.264 millions
Lifevantage Corp-33.62%$ -33.622 millions
Lantheus Holdings Inc -34.06%$ -34.057 millions
Viemed Healthcare Inc -36.61%$ -36.609 millions
Vaso Corporation-44.26%$ -44.257 millions
Nature s Sunshine Products inc -44.42%$ -44.415 millions
Royalty Pharma Plc-44.67%$ -44.675 millions
Globus Medical Inc -44.97%$ -44.968 millions
Amgen Inc -45.90%$ -45.903 millions
Surgery Partners Inc -50.78%$ -50.780 millions
Radnet Inc -52.29%$ -52.294 millions
Option Care Health Inc -53.63%$ -53.635 millions
Pro dex Inc -58.30%$ -58.303 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com